When Does Mounjaro Price Go Up — and What Drives UK Costs?

Step 1: What actually happened to Mounjaro prices in 2025

The price increase that most patients are asking about was an Eli Lilly UK list-price adjustment that took effect on 1 September 2025. Before that date, the highest-strength pen carried a list price of around £122. After it, that same pen's list price rose to approximately £330, a change substantial enough to alter what private clinics and pharmacies were charging almost overnight.

Typical private prices across the dose range have settled in the region of £149 to £375 per month since then, though the exact figure varies by provider and by which dose is prescribed. These are the only £ figures grounded in reported fact; individual providers set their own margins, so you will see variation. For a closer look at how the numbers sit across the range, the breakdown of what each Mounjaro dose costs covers this in more detail.

There is no publicly announced second increase at the time of writing. If you are wondering whether Mounjaro goes up in price beyond the September 2025 adjustment, that question is covered in more detail for patients planning ahead. Patients who want to understand when the Mounjaro price increase takes effect and how it was timed will find a detailed breakdown on that page. A question our prescribers hear most weeks is whether patients should stock up at the current price against a future rise, and for those trying to work out when Mounjaro prices go up and whether there is a reliable pattern to follow, that page addresses the timing question directly. The honest answer is that prescribing decisions are made dose by dose, based on where you are clinically, so over-ordering is not something a responsible prescriber would support.

Step 2: What headline prices often leave out

A price figure quoted per pen or per month tells you the cost of the medicine itself. It does not always tell you the cost of treatment. Those are different things.

Many providers charge separately for the initial consultation, the prescription fee, delivery, and any follow-up clinical reviews before dose changes or repeat supplies. Add those together and a cheaper headline price can end up costing more once you're a few months in. The factors behind Mounjaro's drug price include more than the pen alone.

It is also worth reading the small print on what happens when your dose changes. Titration is a clinical process (Mounjaro starts at 2.5mg as a tolerability step before any therapeutic increase) and that means regular prescriber involvement. If aftercare or dose reviews are billable extras, the treatment cost compounds quickly. NHS England's guidance on weight-management injections sets out what responsible clinical wraparound looks like, which is useful context when comparing private services.

Step 3: What one transparent price actually means at nume

nume sets one price per treatment cycle. That price includes the consultation, the prescription, the medicine, and next-working-day tracked delivery, no separate line items for any of those. If you order by 12pm Monday to Friday and are clinically approved, your treatment ships the same day and arrives the following working day via DPD in plain packaging. Every repeat is reviewed by a GPhC-registered Independent Prescriber before dispatch; clinical suitability is assessed each time, not rubber-stamped.

We are not the cheapest option available. That is deliberate. Running a genuine clinical service with daily prescriber review and a GPhC-registered pharmacy costs more than simply posting a product. Our current treatment prices are listed on the treatment and consultation page, and they do not change with voucher codes or flash sales because we do not run them. You can verify our pharmacy's GPhC registration at number 9012878 via the GPhC register.

If you want to understand what the clinical team behind the service looks like, the prescriber profile sets that out clearly.

Step 4: Why 'cheapest' is the wrong way to judge a prescription medicine

Mounjaro is a prescription-only medicine. The MHRA has been explicit that it is not assessed for quick or cosmetic weight loss, and the regulator has issued repeated warnings about counterfeit pens sold online and through social media. In late 2025 enforcement included the raid of a site in Northampton producing fake tirzepatide pens, and if you are researching Mounjaro discount prices and reduced-price lists in the UK, it is worth knowing that the MHRA has seized around 20 million doses of illegally traded weight-loss medicines worth an estimated £45 million at street value.

Fake pens have contained insulin rather than tirzepatide. The price comparison that matters for a POM is not who charges least; it is whether the supply chain is licensed, the prescriber is real and identifiable, and the pharmacy is on the GPhC register. Sellers offering these medicines without a proper prescription and clinical assessment are a red flag regardless of the price. Report suspect sellers via the MHRA Yellow Card scheme.

For context on whether Mounjaro prices are likely to change again, patients who want to understand when Mounjaro prices will go up and whether there is a pattern they can plan around will find that question addressed alongside the Mounjaro overview, which both carry up-to-date framing. The right starting point, whatever your budget, is a clinical consultation, because suitability comes before cost. Start your free consultation and a real prescriber will review your case the same day.